Cluster Randomized Trial Examining the Impact of Automated Best Practice Alert on Rates of Implantable Defibrillator Therapy
- 1 June 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 12 (6) , e005024
Abstract
Background: Implantable cardioverter-defibrillators (ICDs) are indicated in patients with left ventricular ejection fraction ≤35%, but many eligible patients do not receive this therapy. In this cluster randomized trial, we investigated the impact of a best practice alert (BPA) through the electronic health records on the rates of electrophysiology referrals, ICD implantations, and all-cause mortality in severe cardiomyopathy patients. Methods and Results: Providers in the Heart and Vascular Institute (n=106) and in General Internal Medicine (n=89) were randomized to receive or not receive a BPA recommending consideration for ICD implantation. Patients belonging to the BPA and no BPA groups of providers were followed to the end points of electrophysiology referrals, ICD implantations, and all-cause mortality. Between 2013 and 2015, patients with reduced left ventricular ejection fraction were managed by 93 providers in the BPA (n=997 patients) and 102 providers in the no BPA (n=909 patients) groups. Patients in the 2 groups had comparable baseline characteristics. After a median follow-up of 36 months, 638 (33%) patients were referred to electrophysiology, 536 (27%) received an ICD, and 445 (23%) died. Patients in the BPA group were more likely to be referred to electrophysiology (hazard ratio=1.23; P =0.026), to receive ICD therapy (hazard ratio=1.35; P =0.006), and exhibited a trend towards slightly lower mortality (hazard ratio=0.85; P =0.091). Conclusions: Delivering a BPA through the electronic health record recommending to providers consideration of ICD implantation when the left ventricular ejection fraction is ≤35% improves the rates of electrophysiology referrals and ICD therapy in patients with severe left ventricular dysfunction.Keywords
This publication has 28 references indexed in Scilit:
- Women and minorities are less likely to receive an implantable cardioverter defibrillator for primary prevention of sudden cardiac deathEP Europace, 2011
- Use of a Screening Tool Improves Appropriate Referral to an Electrophysiologist for Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac DeathCirculation: Cardiovascular Quality and Outcomes, 2011
- Mechanisms Underlying the Lack of Effect of Implantable Cardioverter-Defibrillator Therapy on Mortality in High-Risk Patients With Recent Myocardial InfarctionCirculation, 2010
- Defibrillator Implantation Early after Myocardial InfarctionNew England Journal of Medicine, 2009
- Epidemiology of Sudden Cardiac Death: Clinical and Research ImplicationsProgress in Cardiovascular Diseases, 2008
- Racial Disparity in the Utilization of Implantable-Cardioverter Defibrillators Among Patients With Prior Myocardial Infarction and an Ejection Fraction of ≤35%The American Journal of Cardiology, 2007
- Utilization of implantable cardioverter-defibrillators in survivors of cardiac arrest in the United States from 1996 to 2001JACC, 2004
- Primary Prevention of Sudden Cardiac Death in Idiopathic Dilated CardiomyopathyCirculation, 2002
- Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection FractionNew England Journal of Medicine, 2002
- A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1999